Sigma-Tau Finanziaria (Oncaspar Product) Overview

  • Status
  • Acquired/​Merged

  • Latest Deal Type
  • Asset Purch.

  • Financing Rounds
  • 1

Sigma-Tau Finanziaria (Oncaspar Product) General Information

Description

A portfolio of cancer treatment products. The assets is a biologic cancer therapy used as a component of multi-agent chemotherapeutic regimens to treat acute lymphoblastic leukemia (ALL), a rapidly progressing cancer of the white blood cells. It is primarily marketed in the United States, Germany, Poland and certain other countries and is currently under centralized marketing authorization review with the European Medicines Agency.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Primary Industry
Buildings and Property
Other Industries
Biotechnology
Acquirer
Corporate Office
  • Gaithersburg, MD 20878
  • United States

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Sigma-Tau Finanziaria (Oncaspar Product) Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Sigma-Tau Finanziaria (Oncaspar Product)‘s full profile, request access.

Request a free trial

Sigma-Tau Finanziaria (Oncaspar Product) Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
A portfolio of cancer treatment products. The assets is a biologic cancer therapy used as a component of multi-agent che
Buildings and Property
Gaithersburg, MD
0000 0000-00-00
0000000000 0

000000

uat. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolor
0000 000000000
San Mateo, CA
00 As of 0000
00000
00000000 00000

000000

sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad m
0000 000000000
Novato, CA
0000 As of 0000
00000
00000000 00000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Sigma-Tau Finanziaria (Oncaspar Product) Competitors (2)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Sagimet Biosciences Formerly VC-backed San Mateo, CA 00 00000 00000000 00000
Ultragenyx Pharmaceutical Formerly VC-backed Novato, CA 0000 00000 00000000 00000
You’re viewing 2 of 2 competitors. Get the full list »

Sigma-Tau Finanziaria (Oncaspar Product) Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Sigma-Tau Finanziaria (Oncaspar Product)‘s full profile, request access.

Request a free trial

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »